SpectrumOne (SPEONE) Q2 2025 earnings summary

Executive summary

• Net sales for Q2 2025 were SEK 1.5 million, down from SEK 2.8 million year-over-year, with continued operational headwinds and strategic investments shaping the period.

• Strategic investment of USD 2 million in Health Impact Alliance and progress toward listing subsidiary Qbim AB, with SpectrumOne expecting to retain up to 30% ownership post-listing.

• PRISM platform rollout faced delays, but renewed commercial activity is anticipated in the second half of 2025.

Financial highlights

• Q2 2025 EBITDA was SEK -2.7 million, improved from SEK -3.7 million year-over-year.

• EBIT for Q2 2025 was SEK -8.1 million, compared to SEK -11.3 million in Q2 2024.

• Net financial items for Q2 2025 were SEK -0.8 million, down from SEK 105.2 million in Q2 2024 (which included significant one-time gains).

• Earnings per share before dilution for Q2 2025 was SEK -0.02, compared to SEK 0.25 in Q2 2024.

• Cash flow from operating activities after working capital changes was SEK -6.0 million in Q2 2025, versus SEK -53.1 million in Q2 2024.

Outlook and guidance

• Second half of 2025 expected to be pivotal, with Qbim listing, PRISM sales progress, and further developments from HIA and other holdings anticipated.

• Management remains focused on sustainable, long-term value creation and capital allocation to maximize shareholder value.